SoluPet

SoluPet Inc. is a Toronto-based pet health company that develops evidence-backed supplements designed to support canine cognitive health. Its flagship product, Neuronal Defense™, utilizes a proprietary, water-soluble formulation of Coenzyme Q10 (CoQ10) delivered via micelles to enhance intestinal absorption and cross the blood-brain barrier. The company, founded in 2023, leverages over a decade of research, neuroscience, and biotechnology to address Canine Cognitive Dysfunction (CCD), a neurodegenerative condition in aging dogs. Its team includes veterinarians, neuroscientists, and biochemists who emphasize scientific rigor, adhering to FDA Good Manufacturing Practices and utilizing ingredients with FDA self-affirmed GRAS status.

By translating clinical neuroscience into a consumer-focused solution, SoluPet aims to improve the quality of life for senior dogs and their families. The product is marketed as a way to provide cellular energy and antioxidant protection to brain neurons, helping to manage cognitive decline. SoluPet has engaged in strategic international partnerships, such as with CHC Healthcare Group in Asia, to expand access to its cognitive wellness solutions. The company distinguishes itself by focusing on scientific credibility in the pet supplement market, which it identifies as having a gap in robust clinical validation for cognitive aging products.